Prevalence of obesity in treated and untreated patients with attention deficit hyperactivity disorder

References

1. 1.↵
   1. de Hert M,
   2. Correll CU,
   3. Bobes J,
   4. Cetkovich-Bakmas M,
   5. Cohen D,
   6. Asai I, et al.

   Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 52–77.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Mostafaei S,
   2. Kabir K,
   3. Kazemnejad A,
   4. Feizi A,
   5. Mansourian M,
   6. Hassanzadeh Keshteli A, et al.

   Explanation of somatic symptoms by mental health and personality traits: application of Bayesian regularized quantile regression in a large population study. BMC Psychiatry 2019; 19: 207.

   OpenUrl
3. 3.
   1. Sartorius N,
   2. Holt RIG,
   3. Maj M

   , editors. Comorbidity of mental and physical disorders. Indian J Med Res 2016; 144: 786–787.

   OpenUrl
4. 4.
   1. Janse Van Rensburg A,
   2. Dube A,
   3. Curran R,
   4. Ambaw F,
   5. Murdoch J,
   6. Bachmann M, et al.

   Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries. Infect Dis Poverty 2020; 9: 4.

   OpenUrl
5. 5.↵
   1. Kalinin VV

   1. Kutlu A,
   2. Mülayim S

   . Psychiatric Comorbidities and Quality of Life in Epilepsy. In: Kalinin VV, editor. Epileptology The Modern State of Science [Internet]. InTech; 2016 [cited 2021 Feb 6]. Available from: http://www.intechopen.com/books/epileptology-the-modern-state-of-science/psychiatric-comorbidities-and-quality-of-life-in-epilepsy
6. 6.↵
   1. Druss BG,
   2. Walker ER

   . Mental disorders and medical comorbidity. Synth Proj Res Synth Rep 2011: 1–26.
7. 7.↵
   1. Menon B

   . Hypothyroidism and bipolar affective disorder: is there a connection? Indian J Psychol Med 2014; 36: 125–128.

   OpenUrl
8. 8.↵
   1. Chakrabarti S

   . Thyroid functions and bipolar affective disorder. J Thyroid Res 2011; 2011: 306367.

   OpenUrlPubMed
9. 9.↵
   1. Bly MJ,
   2. Taylor SF,
   3. Dalack G,
   4. Pop-Busui R,
   5. Burghardt KJ,
   6. Evans SJ, et al.

   Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disord 2014; 16: 277–288.

   OpenUrlCrossRef
10. 10.↵
    1. Briguglio M,
    2. Vitale JA,
    3. Galentino R,
    4. Banfi G,
    5. Dina CZ,
    6. Bona A, et al.

    Healthy eating, physical activity, and sleep hygiene (HEPAS) as the winning triad for sustaining physical and mental health in patients at risk for or with neuropsychiatric disorders: considerations for clinical practice. Neuropsychiatr Dis Treat 2020; 16: 55–70.

    OpenUrlPubMed
11. 11.↵
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington, (DC): American Psychiatric Association Publication; 2013.
12. 12.↵
    1. Posner J,
    2. Polanczyk GV,
    3. Sonuga-Barke E

    . Attention-deficit hyperactivity disorder. Lancet 2020; 395: 450–462.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Cortese S,
    2. Castellanos FX

    . The relationship between ADHD and obesity: implications for therapy. Expert Rev Neurother 2014; 14: 473–479.

    OpenUrl
14. 14.↵
    1. Jensen PS,
    2. Martin D,
    3. Cantwell DP

    . Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 1997; 36: 1065–1079.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Biederman J,
    2. Newcorn J,
    3. Sprich S

    . Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148: 564–77.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Cortese S,
    2. Vincenzi B

    . Obesity and ADHD: clinical and neurobiological implications. Curr Top Behav Neurosci 2012; 9: 199–218.

    OpenUrlPubMed
17. 17.↵
    1. Cortese S,
    2. Faraone SV,
    3. Bernardi S,
    4. Wang S,
    5. Blanco C

    . Adult attention-deficit hyperactivity disorder and obesity: epidemiological study. Br J Psychiatry 2013; 203: 24–34.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Ng QX

    . A Systematic review of the use of bupropion for attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 2017; 27: 112–116.

    OpenUrl
19. 19.↵
    1. Granato MF,
    2. Ferraro AA,
    3. Lellis DM,
    4. Casella EB

    . Associations between attention-deficit hyperactivity disorder (ADHD) Treatment and patient nutritional status and height. Behav Neurol 2018; 2018: e7341529.

    OpenUrl
20. 20.↵
    1. Levy LD,
    2. Fleming JP,
    3. Klar D

    . Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes (Lond) 2009; 33: 326–334.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Cortese S,
    2. Moreira-Maia CR

    , St. Fleur D, Morcillo-Peñalver C, Rohde LA, Faraone SV. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiatry 2015; 173: 34–43.

    OpenUrlPubMed
22. 22.↵
    Cochrane Training. Review Manager (RevMan). [updated 22; cited 2021 Jul 15]. Available from: https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman
23. 23.↵
    1. Cuschieri S

    . The STROBE guidelines. Saudi J Anaesth 2019; 13: S31–S34.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Curtin C,
    2. Bandini LG,
    3. Perrin EC,
    4. Tybor DJ,
    5. Must A

    . Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review. BMC Pediatr 2005; 5: 48.

    OpenUrlCrossRefPubMed
25. 25.
    1. Visser SN,
    2. Lesesne CA,
    3. Perou R

    . National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics 2007; 119: S99–S106.

    OpenUrlAbstract/FREE Full Text
26. 26.
    1. Waring ME,
    2. Lapane KL

    . Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample. Pediatrics 2008; 122: e1–e6.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Dubnov-Raz G,
    2. Perry A,
    3. Berger I

    . Body mass index of children with attention-deficit/hyperactivity disorder. J Child Neurol 2011; 26: 302–308.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.
    1. Kim J,
    2. Mutyala B,
    3. Agiovlasitis S,
    4. Fernhall B

    . Health behaviors and obesity among US children with attention deficit hyperactivity disorder by gender and medication use. Prev Med 2011; 52: 218–222.

    OpenUrlCrossRefPubMed
29. 29.
    1. Byrd HCM,
    2. Curtin C,
    3. Anderson SE

    . Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes 2013; 8: 445–453.

    OpenUrl
30. 30.
    1. Spencer TJ,
    2. Faraone SV,
    3. Tarko L,
    4. McDermott K,
    5. Biederman J

    . Attention-deficit/hyperactivity disorder and adverse health outcomes in adults. J Nerv Ment Dis 2014; 202: 725–731.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Hanć T,
    2. Słopień A,
    3. Wolańczyk T,
    4. Dmitrzak-Węglarz M,
    5. Szwed A,
    6. Czapla Z, et al.

    ADHD and overweight in boys: cross-sectional study with birth weight as a controlled factor. Eur Child Adolesc Psychiatry 2015; 24: 41–53.

    OpenUrl
32. 32.↵
    1. Cortese S,
    2. Konofal E,
    3. Bernardina BD,
    4. Mouren MC,
    5. Lecendreux M

    . Does excessive daytime sleepiness contribute to explaining the association between obesity and ADHD symptoms? Med Hypotheses 2008; 70: 12–16.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Gami AS,
    2. Caples SM,
    3. Somers VK

    . Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003; 32: 869–894.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Weinberg WA,
    2. Brumback RA

    . Primary disorder of vigilance: a novel explanation of inattentiveness, daydreaming, boredom, restlessness, and sleepiness. J Pediatr 1990; 116: 720–725.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Lecendreux M,
    2. Konofal E,
    3. Bouvard M,
    4. Falissard B,
    5. Mouren-Siméoni MC

    . Sleep and alertness in children with ADHD. J Child Psychol Psychiatry 2000; 41: 803–812.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Barkley RA,
    2. McMurray MB,
    3. Edelbrock CS,
    4. Robbins K

    . Side effects of metlyiphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 1990; 86: 184–192.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Strimas R,
    2. Davis C,
    3. Patte K,
    4. Curtis C,
    5. Reid C,
    6. McCool C

    . Symptoms of attention-deficit/hyperactivity disorder, overeating, and body mass index in men. Eat Behav 2008; 9: 516–518.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Davis C,
    2. Levitan RD,
    3. Smith M,
    4. Tweed S,
    5. Curtis C

    . Associations among overeating, overweight, and attention deficit/hyperactivity disorder: a structural equation modelling approach. Eat Behav 2006; 7: 266–274.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Ng QX,
    2. Ho CYX,
    3. Chan HW,
    4. Yong BZJ,
    5. Yeo WS

    . Managing childhood and adolescent attention-deficit/hyperactivity disorder (ADHD) with exercise: A systematic review. Complement Ther Med 2017; 34: 123–128.

    OpenUrl